Hibiocy Co., Ltd. announced a private placement of 1,150 newly issued preferred shares, having a par value of THB 100 per share, representing 1.01 percent of the total shares sold, at the subscription price of THB 100 per share for gross proceeds of THB 115,000 on October 19, 2022. The transaction included participation from existing investor, Rojukiss International Public Company Limited. Post the completion of the transactions, the investor has hold preferred shares and ordinary shares in total, representing 46.60% of all paid-up shares.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 THB | -1.48% | +2.31% | +49.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+49.77% | 108M | |
-1.67% | 20.17B | |
-18.04% | 19.25B | |
0.00% | 14.3B | |
+10.17% | 10.69B | |
0.00% | 2.43B | |
+722.50% | 2.02B | |
-2.82% | 1.67B | |
-8.70% | 1.61B | |
-59.32% | 544M |
- Stock Market
- Equities
- KISS Stock
- News Rojukiss International
- Hibiocy Co., Ltd. announced that it has received THB 0.115 million in funding from Rojukiss International Public Company Limited